Financial Ratios

RPG LIFE SCIENCES LTD.

NSE : RPGLIFEBSE : 532983ISIN CODE : INE105J01010Industry : Pharmaceuticals & DrugsHouse : RPG Enterprises
BSE1567.5026.25 (+1.7 %)
PREV CLOSE ( ) 1541.25
OPEN PRICE ( ) 1551.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1274
TODAY'S LOW / HIGH ( )1544.70 1580.00
52 WK LOW / HIGH ( )745 1740
NSE1567.3018.55 (+1.2 %)
PREV CLOSE( ) 1548.75
OPEN PRICE ( ) 1552.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1567.30 (76)
VOLUME 22781
TODAY'S LOW / HIGH( ) 1550.00 1588.00
52 WK LOW / HIGH ( )748.6 1740
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)40.9031.1324.1917.546.54
   CEPS(Rs)50.2740.6034.1527.4315.80
   DPS(Rs)12.009.607.204.002.40
   Book NAV/Share(Rs)186.00154.66130.88106.7797.05
   Tax Rate(%)26.2229.6425.3520.4128.17
Margin Ratios
   Core EBITDA Margin(%)18.6618.1816.8714.579.34
   EBIT Margin(%)16.7315.5513.209.545.40
   Pre Tax Margin(%)16.5315.2612.778.874.08
   PAT Margin (%)12.1910.749.537.062.93
   Cash Profit Margin (%)14.9814.0013.4611.037.09
Performance Ratios
   ROA(%)17.7115.8914.0011.254.07
   ROE(%)24.0121.8020.3617.216.86
   ROCE(%)32.9231.4627.2720.359.81
   Asset Turnover(x)1.451.481.471.591.39
   Sales/Fixed Asset(x)2.732.612.372.442.35
   Working Capital/Sales(x)3.443.784.369.5219.12
Efficiency Ratios
   Fixed Capital/Sales(x)0.370.380.420.410.42
   Receivable days23.1734.4152.5245.3853.01
   Inventory Days58.5753.7945.6438.9146.92
   Payable days128.38132.94138.23106.09135.21
Valuation Parameters
   PER(x)17.0117.9816.009.7237.90
   PCE(x)13.8413.7811.346.2115.68
   Price/Book(x)3.743.622.961.602.55
   Yield(%)1.721.721.862.350.97
   EV/Net Sales(x)2.131.941.540.781.35
   EV/Core EBITDA(x)10.109.488.364.8012.64
   EV/EBIT(x)11.7811.4810.857.4622.37
   EV/CE(x)2.612.481.981.552.26
   M Cap / Sales2.242.101.650.751.24
Growth Ratio
   Net Sales Growth(%)16.5113.113.6113.75-4.01
   Core EBITDA Growth(%)20.0425.6117.9872.84-10.63
   EBIT Growth(%)24.4734.6941.2196.94-20.61
   PAT Growth(%)31.3928.7037.88168.36-19.63
   EPS Growth(%)31.3928.7037.88168.36-19.63
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.010.070.23
   Current Ratio(x)2.572.582.211.521.25
   Quick Ratio(x)1.641.551.470.960.72
   Interest Cover(x)80.7252.8930.9314.214.10
   Total Debt/Mcap(x)0.000.000.040.09

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.